Lv1
40 积分 2025-01-05 加入
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
3小时前
已完结
First‐in‐Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants
6个月前
已完结
Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes
6个月前
已完结
Targeted Degradation of ZBP1 with Covalent PROTACs for Anti-Inflammatory Treatment of Infections
8个月前
已完结
Comparison of the efficacy and safety of GLP‐1 receptor agonists on cardiovascular events and risk factors: A review and network meta‐analysis
8个月前
已完结
Once‐daily oral small‐molecule glucagon‐like peptide‐1 receptor agonist lotiglipron (PF‐07081532) for type 2 diabetes and obesity: Two randomized, placebo‐controlled, multiple‐ascending‐dose Phase 1 studies
10个月前
已完结
皖公网安备34019202002308
